Evidence for serotonin receptor subtypes involvement in agmatine antidepressant like-effect in the mouse forced swimming test

Brain Research
Andréa Dias Elpo ZomkowskiAna Lúcia Severo Rodrigues

Abstract

This study investigated the involvement of 5-HT(1) and 5-HT(2) receptors in the antidepressant-like effect of agmatine in the mouse forced swimming test (FST). Pretreatment with p-chlorophenylalanine methyl ester (PCPA; 100 mg/kg, intraperitoneally (i.p.), an inhibitor of serotonin synthesis, for 4 consecutive days), methysergide (5 mg/kg, i.p., a serotonin (5-HT) antagonist), pindolol (32 mg/kg, i.p., a 5-HT(1A/1B) receptor/beta-adrenoceptor antagonist), N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridynyl)cyclohexanecarboxamide (WAY 100635; 0.3 mg/kg, subcutaneously (s.c.), a selective 5-HT(1A) receptor antagonist), 1-(2-methoxyphenyl)-4[-(2-phthalimido)butyl]piperazine) (NAN-190; 0.5 mg/kg, i.p., a 5-HT(1A) receptor antagonist), 1-(2-(1-pyrrolyl)-phenoxy)-3-isopropylamino-2-propanol (isamoltane; 2.5 mg/kg, i.p., a 5-HT(1B) receptor antagonist), cyproheptadine (3 mg/kg, i.p., a 5-HT(2) antagonist) or ketanserin (5 mg/kg, i.p., a 5-HT(2A/2C) receptor antagonist), but not with propranolol (2 mg/kg, i.p., a beta-adrenoceptor antagonist), prevented the effect of agmatine (10 mg/kg, i.p.) in the FST. A subeffective dose of agmatine (0.001 mg/kg, i.p.) produced a synergistic antidepressant-like effect with pindolol (32 mg/...Continue Reading

References

Oct 29, 1991·European Journal of Pharmacology·Y ClaustreB Scatton
Sep 23, 1986·European Journal of Pharmacology·S Hjorth, A Carlsson
Jan 1, 1984·Psychopharmacology·P Willner
Mar 1, 1993·British Journal of Pharmacology·G P LuscombeD J Heal
Nov 1, 1996·Pharmacology, Biochemistry, and Behavior·Y Kitamura, T Nagatani
Jul 1, 1997·Archives of General Psychiatry·R S DumanE J Nestler
Sep 28, 1998·Life Sciences·M O Rojas-CorralesJ A Micó
Jul 23, 1999·Brain Research·S T KaehlerA Philippu
Aug 12, 1999·European Journal of Pharmacology·P Skolnick
Apr 29, 2000·Trends in Pharmacological Sciences·D J Reis, S Regunathan
May 4, 2000·Brain Research·A P SchmidtD Onofre Souza
May 24, 2000·British Journal of Pharmacology·G WegenerR Rosenberg
Jul 7, 2000·Neuroreport·A L EckeliA L Rodrigues
Dec 15, 2000·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·M T AbellánF Artigas
Feb 22, 2001·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·M F O'Neill, M W Conway
Apr 21, 2001·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·F ClenetM Bourin
May 2, 2001·Nature Reviews. Neuroscience·M L Wong, J Licinio
Jul 17, 2001·British Journal of Pharmacology·W RaaschP Dominiak
Jan 12, 2002·Current Opinion in Pharmacology·Derek N MiddlemissJeannette M Watson
Apr 4, 2002·Neuroreport·Andrea D E ZomkowskiAna Lúcia S Rodrigues
Oct 31, 2002·Nature Neuroscience·Charles B Nemeroff, Michael J Owens
Jan 25, 2003·Pharmacology, Biochemistry, and Behavior·Aimee K BencePeter A Crooks
Feb 1, 2003·Biological Psychiatry·Pierre Blier, Nick M Ward
Apr 4, 2003·Behavioural Brain Research·Daniel LavinskyCarlos Alexandre Netto
Jun 16, 2004·Naunyn-Schmiedeberg's Archives of Pharmacology·E C GavioliG Calo'

❮ Previous
Next ❯

Citations

Mar 19, 2013·Behavioural Brain Research·Amber LockridgeLi-Lian Yuan
Jun 7, 2005·Physiology & Behavior·Feyza Aricioglu, Soundar Regunathan
Aug 27, 2011·American Journal of Respiratory and Critical Care Medicine·Deepti NairDavid Gozal
Aug 28, 2014·Journal of Psychiatric Research·Andiara E FreitasAna Lúcia S Rodrigues
Sep 26, 2012·Evidence-based Complementary and Alternative Medicine : ECAM·Liping ChenDongmei Duan
Jan 3, 2015·Pharmacology, Biochemistry, and Behavior·Vivian Binder NeisAna Lúcia S Rodrigues
Jun 19, 2013·Drug Discovery Today·John E PiletzGad M Gilad
Sep 25, 2012·Regulatory Peptides·M TanakaG Telegdy
Jan 4, 2012·Pharmacology & Therapeutics·Gerhard J Molderings, Britta Haenisch
Sep 28, 2010·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·N Farah IdayuEvhy Apryani
Dec 23, 2009·Progress in Neuro-psychopharmacology & Biological Psychiatry·Andiara E FreitasAna Lúcia S Rodrigues
Nov 26, 2009·Pharmacology, Biochemistry, and Behavior·Dan ZhouJiang-Ping Xu
Mar 17, 2009·Progress in Neuro-psychopharmacology & Biological Psychiatry·Daniele G MachadoAna Lúcia S Rodrigues
May 15, 2009·Progress in Neuro-psychopharmacology & Biological Psychiatry·Ricardo W BinfaréAna Lúcia S Rodrigues
Dec 9, 2008·Progress in Neuro-psychopharmacology & Biological Psychiatry·Chandra C CardosoAna Lúcia S Rodrigues
Apr 21, 2007·European Journal of Pharmacology·Mariana P ZeidanNelson H Gabilan
Dec 22, 2006·Progress in Neuro-psychopharmacology & Biological Psychiatry·Daniele G MachadoAna Lúcia S Rodrigues
Oct 24, 2009·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Laura M Fiori, Gustavo Turecki
Feb 9, 2005·Regulatory Toxicology and Pharmacology : RTP·O T GinawiA K Al-Suwailem
Apr 12, 2016·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Vivian Binder NeisAna Lúcia S Rodrigues
Jul 11, 2006·Progress in Neuro-psychopharmacology & Biological Psychiatry·Andrea D E ZomkowskiAna Lúcia S Rodrigues
Apr 29, 2005·Neuropharmacology·Adair R S SantosJoão B Calixto
Jun 13, 2015·Journal of Natural Medicines·H Bonilla-JaimeG Vazquez-Palacios
Dec 29, 2013·Progress in Neuro-psychopharmacology & Biological Psychiatry·Andiara E FreitasAna Lúcia S Rodrigues
Apr 25, 2012·Progress in Neuro-psychopharmacology & Biological Psychiatry·Jardel Gomes VillarinhoJuliano Ferreira

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.